Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleni Panagioti

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Molecular Therapy. Methods & Clinical Development|September 12, 2022
Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an <i>H</i> <i>.</i> <i>pylori</i> immunostimulatory bacterial transgeneKimberly B Viker, Michael B Steele, Ianko D Iankov, et al.
Journal of Leukocyte Biology|August 11, 2023
Cytomegalovirus durably primes neutrophil oxidative burstThomas F Marandu, Michael Dombek, Michael Gutknecht, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2022
STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma modelsGilles Berger, Erik H Knelson, Jorge L Jimenez-Macias, et al.
European Journal of Immunology|March 21, 2019
Peripheral and systemic antigens elicit an expandable pool of resident memory CD8<sup>+</sup> T cells in the bone marrowMaria Fernanda Pascutti, Sulima Geerman, Nicholas Collins, et al.
Nature Communications|June 17, 2026
IDH1-R132H enhances oncolytic HSV-1 therapy by facilitating viral entry and immune activation in gliomaEleni Panagioti, Hunter J Kelley, Alexander L Ling, et al.
Frontiers in Immunology|January 12, 2024
Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor modelJ Bryan Iorgulescu, Neil Ruthen, Ryuhjin Ahn, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Molecular Therapy. Methods & Clinical Development|September 12, 2022
Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an <i>H</i> <i>.</i> <i>pylori</i> immunostimulatory bacterial transgeneKimberly B Viker, Michael B Steele, Ianko D Iankov, et al.
Journal of Leukocyte Biology|August 11, 2023
Cytomegalovirus durably primes neutrophil oxidative burstThomas F Marandu, Michael Dombek, Michael Gutknecht, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2022
STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma modelsGilles Berger, Erik H Knelson, Jorge L Jimenez-Macias, et al.
European Journal of Immunology|March 21, 2019
Peripheral and systemic antigens elicit an expandable pool of resident memory CD8<sup>+</sup> T cells in the bone marrowMaria Fernanda Pascutti, Sulima Geerman, Nicholas Collins, et al.
Nature Communications|June 17, 2026
IDH1-R132H enhances oncolytic HSV-1 therapy by facilitating viral entry and immune activation in gliomaEleni Panagioti, Hunter J Kelley, Alexander L Ling, et al.
Frontiers in Immunology|January 12, 2024
Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor modelJ Bryan Iorgulescu, Neil Ruthen, Ryuhjin Ahn, et al.
Pageof 2